Micro-elimination of Hepatitis C Virus Infection in Uremics

NCT03891550 PHASE3 UNKNOWN

There is a huge gap between the clinical efficacy and community effectiveness in the treatment of chronic hepatitis C in Taiwan. HCV infection prevails in uremic patients with the prevalence of \> 10 % in Taiwan.The current study will be executed in each participating hemodialysis centers by an outreach team of HCV treaters, treating all of the HCV-viremic uremia patients and HD staffs at the same time (group therapy) in each individual HD center (Erase-C campaign) with all oral directly-acting antivirals, to ensure the rates of diagnosis, accessibility, treatment and follow-up.The purpose of the study is to demonstrate a model of care using outreach HCV treaters by implementing the concept of "group therapy" with one-size-fit-all pangenotypic DAA regimen, 12 weeks of sofosbuvir/velpatasvir, in each individual hemodialysis center (Erase-C campaign) to achieve HCV micro-elimination.

Details

Lead sponsor	Kaohsiung Medical University Chung-Ho Memorial Hospital
Phase	PHASE3
Status	UNKNOWN
Enrolment	135
Start date	Mon May 13 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Mon Apr 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Hepatitis C

Interventions

• Epclusa

Countries

Taiwan